Table 1.

The optimal timing of hAFSC administration for eliciting significant therapeutic effect in LPS-induced neonatal sepsis

Timing of hAFSC injection	Survival rate (%)	N	p value
LPS only	50.0	40	–
− 3 h	78.5	28	0.015*
0	56.3	16	0.67
+ 3 h	50.0	18	1.00
+ 24 h	50.0	20	1.00

The chi-squared test between the LPS only and each of the other groups

*p < 0.05